#REMDESIVIR

James Krellenstein

jbkrell

When I was 22, I watched a friend become HIV+ cuz he couldn't afford Truvada PrEP which cost s$1,300/m but costs

tikender panwar

tikender

Remdesivir: Break Patent monopoly-Issue Compulsory Licensehttps://cpim.org/pressbriefs/remdesivir-break-patent-monopoly Price of Remdesivir in the US is $3,000/Rs. 2.25 lakhs, for a 5-day course. 5 Indian companies are in negotiations for m

Francisco Marty, MD

FranciscoMarty_

Just posted in @JAMA_current!Randomized controlled #remdesivir trial of hospitalized patients with moderate #COVID19 pneumonia—those with with infiltrates on imaging with O2 Sats >94% on room-air.#hungergames feel: may the odds be

Spoonerist Forklore

obscuramus

Is Remdesivir a cure all? There are several treatments that have been demonstrated via high quality RCTs to reduce mortality. Never mind IVM, even HCQ+Zithro had stronger evidence of stronger

Chris Morten

cmorten2

In May, @jbkrell & I concluded the US government has a legal claim to co-ownership of the "core" patents on remdesivir, due to intellectual contributions made by USG scientists. @edsilverman

Matthew Herper

matthewherper

So, contrary to things I'm seeing on Twitter, $GILD has NOT shown a mortality benefit for remdesivir this morning. It's suggested one, and that's very different.PR: https://www.gilead.com/news-and-press/press-room/press-releases

Nida Qadir, MD

NidaQadirMD

Just published in @BMJ_latest, an update to our @WHO living guideline on drugs for #COVID19 – this update focuses on #remdesivir & was informed by the results of 4 trials

ice9

__ice9

GS-441524 is substantially less toxic than remdesivir, far easier to synthesize, more soluble, and has essentially identical effects because remdesivir is apparently metabolized into it (in spite of having been

Eric Feigl-Ding

DrEricDing

BREAKING—wow—WHO just recommended **against** the use of @GileadSciences’s drug remdesivir in hospitalized #COVID19 patients, citing “there is currently no evidence that remdesivir improves survival or reduces need for ventilation i

AJ Kay

AJKayWriter

More evidence re: FDA approval of Remdesivir on 10/22 affected hospitalization volume: We aquired internal #covid19 treatment protocol for a large, multi-hospital regional healthcare system: As of 11/3, Remdesivir is

Anon4Q⭐⭐⭐🇺🇸🇺🇸🇺🇸

anonforq

This information was given to me by another nurse who asked that I make it public. It's a lengthy handout and waiver given to patients being treated for Covid-19. Remdesivir

Francisco Marty, MD

FranciscoMarty_

Updated the #RECOVERYtrial topline results summary table of the #dexamethasone arm compared to usual care for treatment of hospitalized patients with #COVID19.Got additional information colleagues shared in Twitter.Thread with some

Blue Canaries

CanariesBlue

Drug for #COVID19 now: #REMDESIVIR : made by GileadGilead holds the PATENT and that means that it has a monopoly on the drug in the US. It's the only company

Arthur Leroux 🇫🇷🇪🇺🇦🇲 ⚪️Ⓜ️

ArtLeroux

[THREAD] C'était passé presque inaperçu et en lisant (l'excellent) article du @canardenchaine on aurait pu se dire que la France n'a pas acheté de #Remdesivir ... Mais voilà il faut

Tálib

talibinfecto

A text in English to everybody read.This pandemics brought me a profound shame of my medical class.I've seen a great part of my class leaving good clinical practices, clinical evalutions,

Francisco Marty, MD

FranciscoMarty_

Tabulated the topline results released by the #recoverytrial team on #hydroxychloroquine & #dexamethasone, and went over their protocol (https://www.recoverytrial.net/results ) to better digest them.Basic stuff:- hospitalized patie

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.